StockData
RadNet, Inc. logo

RadNet, Inc. (RDNT) company profile

RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3056% above fair value
$76.42+0.38 (+0.50%)

Close on Nov 13, 2026Market cap $6.01BP/E –Yield –

About RadNet

Services-Medical Laboratories, SIC 8071

RadNet provides diagnostic imaging services and digital healthcare solutions. The company operates through two primary business segments: Imaging Centers and Digital Health. Its core offerings include outpatient diagnostic imaging services, healthcare management services, medical software development, and specialized radiology technologies. RadNet serves patients, medical practices, and healthcare facilities. Its customer base and reimbursement sources comprise commercial health insurance providers, government programs such as Medicare and Medicaid, workers' compensation plans, and individuals covered under capitation and personal injury arrangements.

The company conducts operations primarily across the United States, maintaining a significant regional footprint in states such as California, Delaware, Florida, Maryland, New Jersey, and New York. RadNet expands its outpatient diagnostic network through local joint ventures, medical clinic partnerships, and acquisitions of imaging facilities. Beyond its domestic operations, the business maintains international activities and entities in the United Kingdom and the Netherlands. The provided annual report text does not state the specific location of the company's corporate headquarters or the exact total count of its imaging facilities.

Summary of the business section of RadNet's latest annual report, written by StockData.

Company profile

Company

Legal name
RadNet, Inc.
Headquarters
Los Angeles, CA
Address
1510 Cotner Ave 90025
Phone
(310) 478-7808
Website
radnet.com
Employees
76, Dec 31, 2018
Industry
Services-Medical Laboratories
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, Los Angeles, California

Stock & identifiers

Ticker
RDNT
Exchange
Nasdaq
IPO date
Jan 3, 1997
Shares outstanding
79M, Aug 6, 2026
Public float
$4.10B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
1-for-2 reverse, Nov 28, 2006
SEC CIK
790526
CUSIP
750491102
ISIN
US7504911022
FIGI
BBG000CXSF54
Share class FIGI
BBG001S75DK5
LEI
529900RECG94V2IZJ970
EIN
13-3326724

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Howard G. BergerPresident, CEO, Director518,315
Alma Gregory SorensenChief Strategy Officer, Director1,218,351
Mital PatelEVP, Chief Operating Officer154,874
Cornelis WesdorpPres & CEO, Digital Health69,075
Stephen M. ForthuberPres & CEO-Eastern Operations527,052
Norman R. HamesPres and COO-West Operations284,217
Michael N. MurdockEVP, Mergers and Acquisitions46,697
Mark StolperEVP, Chief Financial Officer121,943
David Jeffrey KatzEVP and Chief Legal Officer90,866
Ranjan JayanathanChief Information Officer138,198
David L. SwartzDirector214,032
Laura Pastre JacobsDirector29,953
Gregory E. SpurlockDirector8,236
Lawrence L. LevittDirector167,902

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$12.09M$9.28M$3.10M$365$112
FY2024$9.08M$16.35M$2.62M$357$94
FY2023$6.70M$10.10M$2.03M$178$92
FY2022$5.56M$5.56M$2.82M$96$88
FY2021$4.57M$4.57M$1.68M$154$110
FY2020$2.84M$2.84M$1.05M$96$134

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsOtherTotalvs. prior year
Howard G. Berger, M.D.
President and Chief Executive Officer (principal executive officer)(3)
$3.00M–$9.00M$87.97K$12.09M+33%
Mark D. Stolper
Executive Vice President and Chief Financial Officer (principal financial officer)
$700.00K$350.00K$1.75M$33.52K$2.83M+50%
Stephen M. Forthuber
President and Chief Operating Officer - Eastern Operations
$800.00K$400.00K$2.00M$54.49K$3.25M+51%
Norman R. Hames
President and Chief Operating Officer - Western Operations
$800.00K$400.00K$2.00M$38.10K$3.24M+52%
Mital Patel
Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer
$750.00K$375.00K$1.87M$55.59K$3.06M+56%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“eRAD has approximately 76 employees, including a research and development team of 21 software engineers in Budapest, Hungary.”

Corporate history

Events identified from SEC filings

DateEventDetails
May 6, 2025MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 19, 2018Late filingNotification of late filing
Oct 20, 2015Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 12, 2013Late filingNotification of late filing
Jan 2, 2013Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 18, 2012Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 14, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Nov 8, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 8, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 13, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 7, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 4, 2011Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 22, 2010Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 20, 2010Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 6, 2010Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 5, 2010Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 30, 2010MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 17, 2008Late filingNotification of late filing
Jun 8, 2007Auditor changeChange in certifying accountant (8-K Item 4.01)
May 25, 2007Auditor changeChange in certifying accountant (8-K Item 4.01)
May 16, 2007Late filingNotification of late filing
Apr 30, 2007Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 25, 2007Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 17, 2007Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 3, 2007Late filingNotification of late filing
Feb 15, 2007Late filingNotification of late filing
Feb 13, 2007ListingRegistration of securities on an exchange (Form 8-A)
Jan 30, 2007Late filingNotification of late filing
Nov 21, 2006Name changeName changed from PRIMEDEX HEALTH SYSTEMS INC to RadNet, Inc.
Nov 16, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)

See a number that looks wrong?